Clinical Trial: A Single and Multiple Ascending Dose Escalation and Food Effect Study of QX-4533 in Healthy Participants

U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07678463) titled 'A Single and Multiple Ascending Dose Escalation and Food Effect Study of QX-4533 in Healthy Participants' on June 25.

Brief Summary: The primary purpose of this study is to evaluate the safety and tolerability of QX-4533 following oral administration of single and multiple ascending doses in healthy participants.

Study Start Date: July 02

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: QX-4533

QX-4533 tablets

DRUG: Placebo

QX-4533 matched-placebo tablets

Recruitment Status: NOT_YET_RECRUITING

Sponsor: QuantX Biosciences, Inc.

Disclaimer: Curated by HT Syndication....